⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14472921 | 0.65 | HCAR2 (0.33) | — | |
| SCHEMBL3928670 | 0.57 | — | — | |
| SCHEMBL2025314 | 0.51 | — | — | |
| SCHEMBL17848807 | 0.51 | DHODH (0.47) | — | |
| SCHEMBL29223372 | 0.48 | TSHR (0.36) | — | |
| Mellitic Acid SCHEMBL28758936 | 0.48 | CYP1A2 (0.47) | — | |
| SCHEMBL3506509 | 0.46 | — | — | |
| Bicarbonate SCHEMBL8535954 | 0.45 | CA1 (0.83) | — | |
| Bicarbonate SCHEMBL5458669 | 0.45 | — | — | |
| Bicarbonate SCHEMBL853 | 0.45 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022173759-A1 | COMPOSITIONS OF HYDROXY ACIDS WITH SALICYLIC ACID AND USES THEREFORE | Able Derm LLC (US) | 2022-08-18 | — | — | WO | claimed |
| EP-2405886-A1 | TOPICAL PERSONAL CARE AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | Isp Investments Inc. (US) | 2012-01-18 | — | — | EP | claimed |
| WO-2010105052-A1 | TOPICAL PERSONAL CARE AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2010-09-16 | — | — | WO | claimed |
| JP-6145054-A | — | — | None | — | — | JP | disclosed |
| US-12115173-B2 | Compositions of hydroxy acids with salicylic acid and uses therefore | ELBA LABORATORIES (US) | 2024-10-15 | — | — | US | disclosed |
| WO-2022173759-A1 | COMPOSITIONS OF HYDROXY ACIDS WITH SALICYLIC ACID AND USES THEREFORE | Able Derm LLC (US) | 2022-08-18 | — | — | WO | disclosed |
| US-20220249519-A1 | COMPOSITIONS OF HYDROXY ACIDS WITH SALICYLIC ACID AND USES THEREFORE | ELBA LABORATORIES | 2022-08-11 | — | — | US | disclosed |
| CN-108295073-B | Polyfluoro compounds as bruton's tyrosine kinase inhibitors | 浙江导明医药科技有限公司 | 2020-06-16 | — | — | CN | disclosed |
| EP-2405886-B1 | TOPICAL PERSONAL CARE AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | ISP INVESTMENTS INC (US) | 2017-09-27 | — | — | EP | disclosed |
| EP-2405886-A1 | TOPICAL PERSONAL CARE AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | Isp Investments Inc. (US) | 2012-01-18 | — | — | EP | disclosed |
| WO-2010105052-A1 | TOPICAL PERSONAL CARE AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2010-09-16 | — | — | WO | disclosed |
| JP-H06145054-A | METHOD FOR TREATING RE-PERFUSION DAMAGE AND COMPOSITION THEREFOR | CLINTEC NUTRITION CO | 1994-05-24 | — | — | JP | disclosed |